Sporos Bioventures taps first CEO during period of 'explosive growth'; In the wake of murky Hunter syndrome data, Denali bulks up C-suite
Almost five months after emerging from stealth mode on a mission to leverage work being done in “flyover” states like Texas and Wisconsin, Sporos Bioventures has named its first official CEO.
Amit Rakhit left his role as president and CMO of Ovid Therapeutics to take the helm at Sporos, a Houston-based upstart launched by Genzyme vet Michael Wyzga, ex-MD Anderson chief Ron DePinho, BridgeBio co-founder Peter Feinberg, Tvardi Therapeutics CSO Jeno Gyuris, and entrepreneur Alex Cranberg.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.